Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review

Contributing Factors of Neurodegeneration in Alzheimer’s Disease

In: Alzheimer’s Disease [Internet]. Brisbane (AU): Codon Publications; 2019 Dec 20. Chapter 5.
Affiliations
Free Books & Documents
Review

Contributing Factors of Neurodegeneration in Alzheimer’s Disease

Breeya Tailor et al.
Free Books & Documents

Excerpt

Alzheimer’s Disease (AD) affects at least 5.7 million Americans, and it is the sixth leading cause of death in the United States. At the onset, patients experience minor memory problems. Next, impairments in speech and motor function manifest as a limitation to well-being and independence. Slowing this pandemic rise is critical, since AD also bears a huge socioeconomical burden. Unfortunately, there is limited prevention and no effective cure has been found, as all clinical trials for promising AD drugs have failed thus far. The pathological hallmarks of AD include amyloid-β plaques (Aβ), neurofibrillary tangles (NFT), and neuroinflammation. Other factors include APOE4 and environmental stressors, such as metal dyshomeostasis, which contribute to AD pathogenesis. Herein, we review major contributing factors involved in AD pathophysiology. Deeper understanding of associated molecular mechanisms underlying AD pathogenesis is critical for developing novel AD theranostics.

PubMed Disclaimer

References

    1. Alzheimer’s Association 2016 Alzheimer’s disease facts and figures. Alzheimers Dement. 2016;12(4):459–509. doi: 10.1016/j.jalz.2016.03.001. - DOI - PubMed
    1. Selkoe DJ. Alzheimer’s disease is a synaptic failure. Science. 2002;298(5594):789–91. doi: 10.1016/j.jalz.2016.03.001. - DOI - PubMed
    1. Hossini AM, Megges M, Prigione A, Lichtner B, Toliat MR, Wruck W, et al. Induced pluripotent stem cell-derived neuronal cells from a sporadic Alzheimer’s disease donor as a model for investigating AD-associated gene regulatory networks. BMC Genomics. 2015;16:84. doi: 10.1186/s12864-015-1262-5. - DOI - PMC - PubMed
    1. Yuede CM, Timson BF, Hettinger JC, Yuede KM, Edwards HM, Lawson JE, et al. Interactions between stress and physical activity on Alzheimer’s disease pathology. Neurobiol Stress. 2018;8:158–71. doi: 10.1016/j.ynstr.2018.02.004. - DOI - PMC - PubMed
    1. Calderon-Garciduenas L, Vojdani A, Blaurock-Busch E, Busch Y, Friedle A, Franco-Lira M, et al. Air pollution and children: Neural and tight junction antibodies and combustion metals, the role of barrier breakdown and brain immunity in neurodegeneration. J Alzheimers Dis. 2015;43(3):1039–58. doi: 10.3233/JAD-141365. - DOI - PubMed

LinkOut - more resources